B. Marc Averitt Marc is a Co-Founder and Managing Director of Okapi Venture Capital and is responsible for Okapi Ventures' information technology and digital media investments. He has held leadership positions of increasing responsibility in business development, legal, operations, corporate development, and strategy in the technology industry for more than a decade. Prior to founding Okapi, Marc was with Intel Corporation first as an attorney for the Microprocessor Products Group and then as the Director of Strategic Business Development for the Software & Solutions Group worldwide. Prior to Intel, Marc worked for Sun Microsystems in business development and legal roles. Marc received his bachelors from the University of Southern California, where he majored in both Philosophy and Business Administration, and went on to earn his Juris Doctor from Pepperdine University School of Law. Marc has also attended the Stanford University Graduate School of Business Executive Education program. He has traveled extensively throughout the world and has done deals in Argentina, Brazil, Canada, China, Czech Republic, England, Germany, Israel, Japan, Russia, Sweden, and Uzbekistan in addition to the U.S. Marc's present professional board affiliations include My Damn Channel (Director), RF Nano Corporation (Director), Transaction Wireless (Director), Orange County Venture Group (Director; 2008 President), and DATAllegro (Advisor). He is a frequent panelist and speaker for venture capital, M&A, technology commercialization, emerging markets and corporate development. Marc maintains a personal blog about being a VC in "The OC" at http://ocvcblog.com. Sharon Stevenson, DVM PhD Sharon is a Co-Founder and Managing Director of Okapi Venture Capital and is responsible for Okapi Ventures' life science investments. She is a scientifically and financially trained senior executive specializing in innovative strategic problem-solving across functional and industry boundaries. Prior to founding Okapi, Sharon was the Senior Vice President of Technology and Planning for SkinMedica - a private, venture-backed, commercial stage specialty pharmaceutical company focused on the dermatology and human appearance markets. Prior to SkinMedica, Sharon was a Principal with Domain Associates, LLC - a venture capital fund specializing in life science investments. In addition to performing due diligence and working closely with portfolio companies while at Domain, she also served as President and CFO of Volcano Therapeutics (Nasdaq: VOLC) and lead the company's growth from 1 to 14 employees and from the initial design of the first product to the first clinical trials using the device. In addition to her responsibilities at Volcano, Sharon's past and present board affiliations on behalf of Domain include MicroVention (acquired by Terumo Corporation, OTC: TRUMF.PK), Neuropace, NuVasive (Nasdaq: NUVA), Santarus (Nasdaq: SNTS), SkinMedica, and GenVault. Prior to launching her entrepreneurial / venture capital career several years ago, Sharon was a tenured Associate Professor in the Department of Orthopedics at the Case Western Reserve University School of Medicine. She is author of over 132 publications, including 2 guest editorships and has made more than 57 presentations to professional audiences. Her clinical training was in veterinary surgery and she is a Diplomate of the American College of Veterinary Surgeons (ACVS). She has served on the governing boards of the ACVS and the Orthopedic Research Society. Sharon has been awarded a MBA from the UCLA Anderson Graduate School of Management; a PhD in Comparative Pathology from UC Davis; and a Master of Science in Veterinary Pathology and Doctor of Veterinary Medicine from The Ohio State University.